Metabolic acidosis is a frequent and potentially serious medical condition that occurs when the body produces too much acid or when the kidneys are not able to effectively remove acid from the body. Non-anion gap metabolic acidosis (NAGMA) is a specific type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. This type of acidosis is typically caused by a variety of medical conditions, such as kidney failure, certain medications, and certain genetic disorders. In this article, we will explore the causes and treatment options for NAGMA. We will discuss the various medical conditions that can cause NAGMA, the medications that can contribute to this condition, and the genetic disorders that can lead to NAGMA. We will also discuss the various treatments available for NAGMA, including lifestyle changes, medications, and other treatments.
Non-anion gap metabolic acidosis (NAGMA) is a type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. This type of acidosis is typically caused by a variety of medical conditions, such as kidney failure, certain medications, and certain genetic disorders. NAGMA is a type of metabolic acidosis that is characterized by an abnormally high level of acid in the blood. The acidity of the blood is measured using the anion gap, which is the difference between the concentrations of the two main types of electrolytes in the blood: anions and cations. In NAGMA, the anion gap is normal, meaning that the levels of anions and cations are equal.
What Causes Non-Anion Gap Metabolic Acidosis?
NAGMA is typically caused by a variety of medical conditions, medications, and genetic disorders. The most common causes of NAGMA include:
Kidney Failure
Kidney failure is one of the most common causes of NAGMA. When the kidneys are not functioning properly, they are unable to filter out the acids that are produced in the body, leading to an accumulation of acid in the blood.
Medications
Certain medications, such as diuretics and antifungal medications, can also cause NAGMA. These medications can interfere with the body’s ability to filter out acids, leading to an accumulation of acid in the blood.
Genetic Disorders
Certain genetic disorders, such as inherited metabolic disorders, can also lead to NAGMA. These disorders can interfere with the body’s ability to process and eliminate acids, leading to an accumulation of acid in the blood.
The treatment of NAGMA depends on the underlying cause of the condition. In some cases, lifestyle changes may be enough to reduce the acid levels in the blood. In other cases, medications may be needed to reduce the acid levels in the blood. In some cases, other treatments, such as dialysis, may be necessary.
Non-anion gap metabolic acidosis (NAGMA) is a type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. NAGMA is typically caused by a variety of medical conditions, medications, and genetic disorders. The treatment of NAGMA depends on the underlying cause of the condition, and may include lifestyle changes, medications, and other treatments.
1.
Sports for girls are frequently abandoned due to uniform issues.
2.
November 2023, Medical Bulletin 04/.
3.
Induction Immunotherapy Has Durable Survival Benefit in LACC
4.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
5.
Smartphone App Detects Eye Cancers From Photos
1.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
2.
Exercise Capacity During Cancer Recovery: Clinical Evidence, Mechanisms, and Practical Implications
3.
From Bruises to Blood Clots: Everything You Need to Know about Hematoma
4.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
5.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Importance of Cancer Screening and Early Detection
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
Navigating the Complexities of Ph Negative ALL - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation